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Among the micro-organisms discovered by Escherich, he intensively investigated the 
“Bacterium coli commune”, which 8 years after his death in 1911, was named for the 
first time “Escherichia coli”. This posthumous honour made Escherich worldwide 
known in the medical profession. The importance of Escherichia coli among 
commensal in the gut and as pathogenic bacteria in the gut and at other mucosae is 
immense. Additionally, since the birth of molecular cloning, E. coli has been used as 
a host for introduced DNA sequences and today, it still is used in labs worldwide as 
a host for foreign DNA sequences and their protein products.  
The first meeting on E. coli and the mucosal immune system (ECMIS) was organized 
in the beautiful city of Ghent at the Faculty of Bioscience Engineering exactly 100 
years after Escherich’s death. Four years later Eric Cox, Bert Devriendt and Herman 
Favoreel (Laboratory of Immunology, UGent) organized a second meeting in 
cooperation with their colleagues Daisy Vanrompay (Bioscience Engineering, UGent), 
Henri De Greve (VIB lab of structural and Molecular Biology, Free University of 
Brussels), Bruno Goddeeris (Faculty of Bioscience Engineering, KULeuven) and 
Jacques Mainil (Departement of Infectious Diseases, Université de Liège). The 
location was now “het Pand”, a beautiful old Dominican monastery located in the 
heart of the city on the banks of the river Leie, which has become the culture and 
congress centre of Ghent University. 
The meeting aimed to bring together basic scientists and clinicians working on 
Escherichia coli and the mucosal immune system in particular focusing on the 
interaction of these intriguing microorganisms with the mucosal epithelium, on the 
mechanisms they use to modulate the host immune response and on progress in 
prevention and vaccination strategies for humans and animals. Fourteen international 
specialists with outstanding reputation in their fields were invited to present their 
newest data. Furthermore, 24 submitted abstracts were selected for oral presentations 
and 20 additional posters were displayed.  
In this special edition of Veterinary Microbiology, several of the great presentations 
during the symposium can be found, starting with the keynote lectures by Harry 
Dawson, one of the pioneers in comparing the genome and transcriptome of different 
species. In his paper he gives an in-depth comparison of porcine, murine and human 
inflammasome and links this with E. coli. Four of the papers in this issue deal with a 
group of E. coli that uses the type III secretion system and intimin to interact with 
intestinal epithelial cells (Shiga toxin producing E. coli STEC/ enterohaemorrhagic E. 
coli (EHEC)/enteropathogenic E. coli (EPEC)): one paper describes the virulotypes of 
enterohaemolysin-producing E. coli, serotyped positive isolates and compared human 
and calf isolates (Fakih et al. ); three papers deal with the effects of lactoferrin, a 
natural antimicrobial, on E. coli O157:H7 (Rybarczyk et al.; Kieckens et al., 
Rybarczyk et al.). A subsequent paper describes the role of different phagocytes in the 
war against attaching-and-effacing bacterial pathogens using Citrobacter rodentium 
in mice as a model for EPEC /EHEC (Poulin and Chamaillard). Then six papers have 
enterotoxigenic E. coli (ETEC) as central theme. Nguyen et al. describe the 
prevalence of genetic susceptibility for F4 fimbria and for F18 fimbriae producing E. 
coli in the Flemish pig population. Roubos-Van den Hil et al. optimized an F4ac 
infection model in pigs taking into account the MUC4 polymorphism. Coddens et al. 
show that cranberry extract is effective against colonization of the porcine small 
intestinal mucosa with F4 and F18+ E. coli. Cranberry is known for its beneficial 
effect on infections with uropathogenic E. coli but an effect on enterotoxigenic E. coli 
had not been described yet. Even though several molecules can interfere with 
colonisation, one of the main goals in the battle against ETEC and STEC infections 
remains the development of effective vaccines. One of the hurdles to be taken towards 
an ETEC vaccine is the poor immune response against the heat-stable enterotoxins 
(ST) of ETEC. Zhu C et al. engineered a live attenuated vaccine vector of E. coli that 
produces an LT-ST fusion protein that could increase immunogenicity. Rausch et al. 
choose for a different strategy. They constructed a toxoid multiepitope fusion antigen 
that could induce neutralizing antibodies against STa, STb, LT enterotoxins but also 
against the Shiga toxin 2e (Stx2e) produced in pigs by some F18ab+ E. coli. Zhang et 
al. analysed immunisation of mice with CS21 pili or its major subunit LngA and 
demonstrated inhibition of gut colonization of infection in one of the rare ETEC 
mouse models. CS21 is one of the most prevalent coli surface antigens of human 
ETEC. 
We hope you will read this special edition of Veterinary Microbiology with highlights 
out of one of the most trilling recent symposiums on pathogenic E. coli in humans, 
calves, pigs and mice, with as much pleasure as we attended the ECMIS meeting and 
we hope to see you back on one of our next meetings. 
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